NANETS produces a weekly publication, Weekly Net Connection. It contains information on recent NET disease research, guidelines and resources. It also highlights NET continuing medical education (CME) programming, medical society developments, member accomplishments and news from other NET organizations. Have news to share? Contact us! Net News is a benefit of membership in NANETS. Not a member? Subscribe now!

Last week's Eastern Virtual Regional Conference welcomed nearly 200 healthcare professionals and patients for a full day of education and networking.

CaptureVFairsImages NANETS

NANETS' Eastern Virtual Regional Conference included a dynamic half-day of continuing NET medical education. Sessions included:
Overview of Neuroendocrine Tumors
Surgical Treatment of NETs
Medical Management of NETs
Break Out Sessions:
Practical Aspects of Running a PRRT Program
Early Career Discussion Group
Allied Health Discussion Group
NET Tumor Board

On Wednesday, April 28, 2021, NANETS members and patient advocates joined Mark Lewis, MD as he spoke to the value of Twitter in the medical community. This webinar was presented by the NANETS Communications Committee and moderated by Communications Committee Chair Heloisa Soares, MD, PhD.

Watch this recording and share with your colleagues to understand the power of Twitter for professional development. 

The Pancreas Journal of Neuroendocrine Tumors and Pancreatic Diseases and Sciences has published the North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma in the April 2021 issue. Members can access these guidelines by logging in as a member and accessing Pancreas Journal.

These guidelines represent the latest work from NANETS' Guidelines Committee, led by Lauren Fishbein, MD, PhD, MTR, Chair, Janice Pasieka, MD, Co-Chair, and Jennifer Chan, MD, MPH, Past Chair. Since 2013, NANETS has published ten guidelines.

"NANETS consensus guidelines on metastatic pheo/para were created to provide guidance in the diagnosis and treatment of these rare tumours. This comprehensive document was designed to fill in the current gaps in the field and identified areas for future clinical and translational research," said Dr. Pasieka.

"Guidelines on how to treat and monitor those with metastatic pheochromocytoma/paraganglioma were lacking. The NANETS initiative to create an expert consensus guideline on this rare disease topic serves to inform and guide physicians from multiple disciplines on the various treatment options and best practices," noted Dr. Fishbein.

Access to these and other Pancreas articles is a benefit of being a NANETS member. Visit our membership page to join today.
Authors Include: Lauren Fishbein, MD, PhD; Jaydira Del Rivero, MD; Tobias Else, MD; James R. Howe, MD; Sylvia L. Asa, MD; Debbie L. Cohen, MD; Patricia L.M. Dahia, MD, PhD; Douglas L. Fraker, MD; Karyn A. Goodman, MD; Thomas A. Hope, MD; Pamela L. Kunz, MD; Kimberly Perez, MD; Nancy D. Perrier, MD; Daniel A. Pryma, MD; Mabel Ryder, MD; Aaron R. Sasson, MD; Michael C. Soulen, M; and Camilo Jimenez, MD.

Click to access Pheo Para Guidelines.